New product, ready-to-use linearity and calibration verification kits
Products are for professional/laboratory use only.
LGC Maine Standards is a market leader for linearity and calibration verification products.
VALIDATE® ready-to-use linearity and calibration verification kits for human diagnostic analysers.
VALIDATE® products also aid when troubleshooting instrument systems, reagent problems, and calibration anomalies.
Key advantages of VALIDATE® products:
- Multiple product configurations are available to meet the different needs of the many instrument systems available.
- Configurations are specifically formulated to maximize reportable ranges with minimum dilutions.
Comparison of Recovered Value vs. Concentration
Assaying materials in the same manner as patient samples, using VALIDATE®, confirms that an instrument, kit or test system has remained stable throughout the reportable range. Therefore, laboratories can expand beyond the routine quality control range with confidence.
The laboratory can not ensure that the response curve is linear beyond the limits of the calibrator and controls. When a patient sample result falls outside this range, there is reduced confidence that the result is valid. VALIDATE® challenges the extremes of the reportable range. Assaying five levels, using the equal-delta protocol prescribed by CLSI EP06-A, verifies a linear response. Patient samples are reported with increased confidence.
Configurations Tailor-Made to Analytical Instrument Platforms
Clinical Chemistry & Immunoassay Analysers
- Abbott Laboratories
- Beckman Coulter
- Ortho Clinical Diagnostics
- Roche Diagnostics
- Siemens Healthineers
Haemostasis Analysers
- Diagnostica Stago
- Instrumentation Laboratory
- Siemens Healthineers
VALIDATE® Products
VALIDATE® offers more than 165 analytes, formulated into standard groupings.
Visit VALIDATE® PRODUCTS (mainestandards.com) to view the multiple range coverages for each analyte and use the Analyser Search Tool to identify the recommended products for your specific analysers.
